Jubilant Cadista Pharmaceuticals, Inc. recalls clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceutic
Recalled December 2, 2020 · FDA recall D-0104-2021 · Jubilant Cadista Pharmaceuticals
Hazard
Failed Tablet/Capsule Specification · FDA Class II
Units
4,416 bottles
Sold at
Product was distributed nationwide.
Description
Failed Tablet/Capsule Specification
Product
clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD NDC 59746-711-30
Manufacturer(s)
Jubilant Cadista Pharmaceuticals, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →